Skip to main content
Clinical Trials/NCT05719077
NCT05719077
Completed
N/A

Study 3. Pilot Testing Feasibility, Acceptability, and Preliminary Efficacy of a Dementia-Enhanced Training and Tool for Home Hospice Clinicians in a Clinical Setting.

Rutgers, The State University of New Jersey1 site in 1 country93 target enrollmentOctober 6, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Alzheimer's Disease and Related Dementias
Sponsor
Rutgers, The State University of New Jersey
Enrollment
93
Locations
1
Primary Endpoint
Family Caregiver Burden
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

The purpose of this study is to pilot test the feasibility, acceptability, and preliminary efficacy of a clinically useful, inclusive dementia-enhanced training and tool for use by home hospice clinicians to improve care and support for Black and White patients with dementia and their family caregivers. The investigators expect family caregivers of clinicians in the intervention group will report less caregiver burden (primary outcome) than caregivers of clinicians in the control group. The investigators expect that, compared to clinicians in the control group (usual care), clinicians in the intervention group (receive the training and use the tool) will demonstrate more knowledge of dementia-related caregiving issues (secondary outcomes). In exploratory analyses, the investigators expect family caregivers will report greater self-efficacy and preparedness, and that patients of clinicians in the intervention group will experience fewer live discharges than family caregivers of patients of clinicians in the control group.

Detailed Description

For this aim, the investigators will conduct a randomized pilot study to determine the feasibility and acceptability of implementing the training and tool in clinical practice compared to usual care with 40 clinicians (20 intervention, 20 control) and 160 Black and white FCG (80 intervention, 80 control). The investigators will also determine preliminary efficacy of the training and tool. Outcomes include feasibility and acceptability of the intervention, reducing FCG burden (primary outcome), improving clinician knowledge and confidence (secondary outcomes) and increasing FCG preparedness and self-efficacy.

Registry
clinicaltrials.gov
Start Date
October 6, 2023
End Date
December 24, 2025
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elizabeth A. Luth, PhD

Assistant Professor

Rutgers, The State University of New Jersey

Eligibility Criteria

Inclusion Criteria

  • Individuals are not excluded from this study based on gender.
  • Based on proportion of hospice workforce and family caregivers that are female, we expect 70%-80% of participants will be female.
  • Nurse, social worker, or family member who provides care to persons(s) living with dementia enrolled in home hospice care.
  • 19-90 years old.
  • Can complete data collection in English.
  • Family Caregivers: identify as White or Black/African American.

Exclusion Criteria

  • Participant is less than 19 years old or older than 90 years old.
  • Does not provide care to person(s) living with dementia enrolled in home hospice.
  • Cannot complete data collection in English.
  • Family Caregiver does not identify as White or Black/African American.

Outcomes

Primary Outcomes

Family Caregiver Burden

Time Frame: Baseline and through first subsequent hospice visit, an average of 8 weeks

The investigators will assess this outcome using the validated, 12-item Zarit Caregiver Burden Inventory. The investigators will assess changes in reported caregiver burden between baseline and the frist subsequent hospice visit and compare differences in changes between the intervention and control groups. Because family caregiver participants are relatives of hospice patients that may die (at which point they will no longer be receiving home visits from nurses and social workers), the investigators expect that many participants will not complete all four time points of data collection.

Secondary Outcomes

  • Clinician knowledge of dementia-related issues at end of life(Baseline and through training completion, an average of 4 weeks)

Study Sites (1)

Loading locations...

Similar Trials